Effepharm Ltd

Effepharm-Ltd.jpg

At Effepharm, we apply science and technologies to improve health and well-being at every stage of life with innovative thinking.

Effepharm is a raw material imperfection finder and innovative ideas and solutions provider, generally focusing on the manufacturing and bio-availability of nutritional ingredients at present. At the same time, we aim at helping our partners to reduce the cost of raw material supply chains and improve their market competitiveness with raw materials of super quality and competitive price optimized by innovative technology.

UTHEVER®(Beta-Nicotinamide Mononucleotide) from Effepharm has been the most popular branded ingredient in the antioxidant supplements industry and Effepharm is recognized as the most reliable NMN supplier of NMN brands and distributors. Effepharm also supplies below several ingredients: PEA, Liposomal Vitamin C, Fisetin, Pterostilbene....

Our dedicated team strive to set the standard for quality, safety and value in the discovery, development and manufacturing of health ingredients for people. Sparing no effort to deliver more reliable and affordable health ingredients around the world, Effepharm is making a difference for all who rely on us.

Latest Content

Related Resources

Discover UTHEVER® NMN’s Global Regulatory Landscape

Discover UTHEVER® NMN’s Global Regulatory Landscape

Paid for by Effepharm Ltd

White Paper

NMN has long faced regulatory challenges. Today, that landscape is changing. We consistently invest in scientific research & quality development, aiming to establish UTHEVER® as the world’s most compliant NMN ingredient brand.

The Only & 1st NMN Got Novel Food EFSA Positive Safety Opinion

The Only & 1st NMN Got Novel Food EFSA Positive Safety Opinion

Paid for by Effepharm Ltd

White Paper

On 11th May 2026, EFSA officially published a positive scientific opinion on EffePharm’s β-NMN as a novel food. This is the first-ever EU official safety endorsement for NMN. UTHEVER® is the 1st NMN ingredient brand to receive EFSA’s positive opinion.

Uthever® NMN: Novel Food Approval Nearing Final Stage

Uthever® NMN: Novel Food Approval Nearing Final Stage

Paid for by Effepharm Ltd

White Paper

One Step Away from EU Market Compliance for NMN. The official positive opinion of Novel Food is expected to be published shortly, which means Uthever® NMN will be the first compliant ingredient.